Skip to content
Riskpilot
← Back to search
Sign in
Get full access
DANSAC AND HOLLISTER SCANDINAVIA INC. (USA) FILI
UJP
Active
Org 5164025297
Enhagsslingan 5, 187 40
Täby
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1996 · 29 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
DANSAC AND HOLLISTER SCANDINAVIA INC. (USA) FILI
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
Sd
Sebastiaan de Jong
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
LE
Liv Etholm
Chief Executive Officer
Chief Executive Officer
2022
MJ
Morten Just Hansen
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
KJ
Karl Jonatan Nilsson
Chief Auditor
Chief Auditor
2021
Former (2)
KM
Kajsa Maria Malmsten
Chief Executive Officer
Chief Executive Officer
2023 – 2023
JC
Jesper Carl John Wiklander
Chief Executive Officer
Chief Executive Officer
2021 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on DANSAC AND HOLLISTER SCANDINAVIA INC. (USA) FILI
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
